ID: ALA4796054

Max Phase: Preclinical

Molecular Formula: C48H58N2O7

Molecular Weight: 775.00

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CCCCCCCCCC(=O)Oc1c(OC)cc2c3c1Oc1cc4c(cc1OC)CCN(C)[C@H]4Cc1ccc(cc1)Oc1cc(ccc1OC)C[C@@H]3N(C)CC2

Standard InChI:  InChI=1S/C48H58N2O7/c1-7-8-9-10-11-12-13-14-15-45(51)57-47-44(54-6)30-35-23-25-50(3)39-27-33-18-21-40(52-4)42(28-33)55-36-19-16-32(17-20-36)26-38-37-31-43(56-48(47)46(35)39)41(53-5)29-34(37)22-24-49(38)2/h7,16-21,28-31,38-39H,1,8-15,22-27H2,2-6H3/t38-,39-/m0/s1

Standard InChI Key:  PVWJWWKROGQNBQ-YDAXCOIMSA-N

Associated Targets(Human)

HEL 6614 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 775.00Molecular Weight (Monoisotopic): 774.4244AlogP: 10.37#Rotatable Bonds: 13
Polar Surface Area: 78.93Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.27CX LogP: 10.20CX LogD: 8.98
Aromatic Rings: 4Heavy Atoms: 57QED Weighted: 0.06Np Likeness Score: 1.47

References

1. Yang J,Hu S,Wang C,Song J,Chen C,Fan Y,Ben-David Y,Pan W.  (2020)  Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.,  186  [PMID:31784186] [10.1016/j.ejmech.2019.111898]

Source